PDPN has been reported to identify “a subset of aggressive and radiation-resistant glioblastoma cells” [47] and predict “poor prognosis in patients with glioma” [48] and that it “contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma” [49]. This evidence concerns the gene IDH1 and glioma.